Searchable abstracts of presentations at key conferences on calcified tissues

ba0001pp169 | Cell biology: osteoblasts and bone formation | ECTS2013

Increase of mineral nodules and alkaline phosphatase levels in osteoblasts cultures by using disordered carbon nanotubes and titanium discs

Zancanela Daniela Cervelle , Simao Ana Maria Sper , Matsubara Elaine Yoshiko , Rosolen Jose Mauricio , Ciancaglini Pietro

Biological calcification is a regulated process in which different types of tissues, cells and biomolecules participate in the coordination and regulation of the metabolic events involved in accumulating large amounts of calcium phosphate. This process could be speeded up using carbon nanotubes (CNTs) systems. The objective of our study was to compare cell growth and formation of mineralized matrix nodules by osteoblasts grown in plastic and in titanium (Ti) discs surfaces. Th...

ba0001pp170 | Cell biology: osteoblasts and bone formation | ECTS2013

Calcium transport and phosphomonohydrolase activity by proteoliposomes harboring annexin V and alkaline phosphatase

Bolean Mayte , Simao Ana Maria , Kiffer-Moreira Tina , Hoylaerts Marc , Millan Jose Luis , Ciancaglini Pietro

The biomineralization process is initiated inside matrix vesicles (MVs), with phosphate and calcium ions crystallizing as hydroxyapatite. This process is accomplished by the activities of several proteins, such as annexins (e.g. AnxV) that mediates Ca2+ influx into MVs and tissue-nonspecific alkaline phosphatase (TNAP), a phosphomonohydrolase that uses ATP and PPi as substrates. Dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylserine (DPPS...

ba0001pp199 | Cell biology: osteoblasts and bone formation | ECTS2013

Effect of β-cryptoxanthin on the differentiation of human bone-marrow stromal stem-cells treated with pioglitazone

Casado-Diaz Antonio , Santiago-Mora Raquel , Dorado Gabriel , Quesada-Gomez Jose Manuel

Pioglitazone is a drug of the thiazolidinedione (TZD) class used to treat type 2 diabetes mellitus. TZD is an agonist of peroxisome proliferator-activated receptor γ (PPAR-γ) that improves insulin sensitivity, glucose and lipid metabolism and inflammation. However, TZD induces bone marrow adiposity with suppression of osteogenesis, that could contribute to bone loss and osteoporotic fractures. β-Cryptoxanthin is a carotenoid with antioxidant properties abundant ...

ba0001pp204 | Cell biology: osteoblasts and bone formation | ECTS2013

Non-canonical BMP signaling in bone healing

Sanchez-Duffhues Gonzalo , de Vinuesa Amaya Garcia , Kloen Peter , Goumans Marie-Jose , ten Dijke Peter

The healing of bone fractures is a tightly regulated process where released growth factors and cytokines interplay within an inflammatory environment in order to reestablish the functional bone. Recent studies have suggested that endothelial cells may dedifferentiate into mesenchymal multipotent cells via a mechanism called endothelial-to-mesenchymal-transition (EndoMT). Transforming growth factor-β (TGF-β) plays a critical role inducing EndoMT. Subsequent differenti...

ba0001pp234 | Cell biology: osteoclasts and bone resorption | ECTS2013

Do ecto-nucleotidases play a role in the regulation of osteoclast function?

Hajjawi Mark , MacRae Vicky , Huesa Carmen , Millan Jose Luis , Arnett Timothy , Orriss Isabel

Extracellular nucleotides stimulate both the formation and resorptive activity of osteoclasts. Ecto-nucleotide pyrophosphatase/phosphodiesterases (NPPs) hydrolyse extracellular nucleotide triphosphates to their corresponding monophosphate and pyrophosphate (PPi). We investigated if osteoclasts express functional NPPs and whether Enpp1 gene deletion influenced osteoclast formation and activity. Osteoclasts were formed from the bone marrow of 8 and 15 week old knockou...

ba0001pp284 | Muscle, physical activity and bone | ECTS2013

Raising CK: what it means according to different clinical landscape?

Juan Jose Scali , Visentini Susana , Berruezo Ramiro , Sevilla Daniel , Pacheco Gonzalo , Garcia Rodrigo

Introduction: The creatine kinase (CK) is a dimeric enzyme, involved in energetical metabolism. It is present in many tissues, but higher concentration in skeletal and cardiac muscle.Therefore, conditions that involve muscle tissue may increase this serum enzyme. Such enzyme elevation is usually observed in inflammatory myopathies and others autoimmune diseases.Sometimes some elevation in CK is not fully understood out off these co...

ba0003oc5.1 | Important pathways in bone biology and cancer | ECTS2014

In vivo efficacy of a pharmacological inhibitor of TNAP to prevent arterial calcification and its associated cardiac hypertrophy and mortality

Sheen Campbell , Chhea Thangchanthida , Pinkerton Antony , Jackson Michael , Millan Jose Luis

Medial vascular calcification (MVC) is a pathological condition common to a variety of diseases, including chronic kidney disease, diabetes, obesity, generalized arterial calcification of infancy, arterial calcification due to deficiency of CD73, and Keutel syndrome. These diseases share the common feature of tissue-nonspecific alkaline phosphatase (TNAP) upregulation in the vasculature. We developed a mouse model that overexpresses human TNAP in vascular smooth muscle cells, ...

ba0004p116 | (1) | ICCBH2015

Osteopetrosis with uncommon final height: can only local IGF1 hold normal growth during pubertal spurt?

Milani Soraya Sader , Paula Francisco Jose , Liberatore Jr Raphael , Martinelli Jr Carlos Eduardo

Background: Final stature is a result of concomitant growth hormone (GH)-IGF1 axis integrity, a healthy environment and genetic background. Occasionally, growth occurs despite remarkable impairment in hormone profile. Presenting problem: An uncommon case of longitudinal growth in a boy with very low IGF1 concentrations and clinical diagnosis of osteopetrosis. Clinical management: We report on the case of a 19 year-old male patient with the diagnosis of osteopetrosis who had a ...

ba0005oc2.4 | Bone mass and bone strength Wnt signalling | ECTS2016

Up-regulation of Wnt antagonists contributes to the attenuated response of bone formation to repeat doses of sclerostin antibody in a mouse model

Holdsworth Gill , Greenslade Kevin , Stencel Zofia , Jose Joby , Kirby Hishani , Moore Adrian , Robinson Martyn , Ke David

Loss of the gene encoding the secreted Wnt antagonist sclerostin results in increased bone mass in humans and mice. Administration of antibodies to sclerostin (Scl-Ab) has been shown to increase bone mineral density (BMD) by increasing bone formation and decreasing bone resorption, in both animal studies and human clinical trials. In these studies, the magnitude and rate of increase in bone formation markers, and the rate of increase of BMD, diminishes upon repeat dosing with ...

ba0007p109 | (1) | ICCBH2019

Fracture prevalence in children 0–19 years-old in Mexico: A 10-year cross-sectional analysis

Clark Patricia , Barbato Annarella , Guagnelli Miguel Angel , Rascon Jose Alberto , Denova Edgar , Borja Victor Hugo

Fracture prevalence in children appears to change in recent years due to variations in physical activity and enforcement of laws that protect children within motor vehicles. However, in Mexico such variation has not been explored so far.Objective: To analyze fracture prevalence in the paediatric population of Mexico to detect patterns of change in time, between genres and among different diagnoses.Methods: We analyzed data from the...